Mechanisms of nonfatal acute myocardial infarction late after stent implantation: The relative impact of disease progression, stent restenosis, and stent thrombosis

American Heart Journal

Volumn 159, Issue 3, 2010, Pages 439-445

  Alexopoulos, Dimitrios ^a   Xanthopoulou, Ioanna ^a   Davlouros, Periklis ^a   Damelou, Anastasia ^a   Mazarakis, Andreas ^a   Chiladakis, John ^a   Hahalis, George ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY STENT; DISEASE COURSE; DRUG ELUTING STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PRIORITY JOURNAL; ST SEGMENT ELEVATION; STENT THROMBOSIS;

AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DISEASE PROGRESSION; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; STENTS; THROMBOSIS; TIME FACTORS;

EID: 77649250571     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.12.011     Document Type: Article

References (23)

1. Kimura T., Abe K., Shizuta S., et al. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 105 (2002) 2986-2991
2. Van Domburg R.T., Foley D.P., de Jaegere P., et al. Long term outcome after coronary stent implantation: a 10 year single center experience of 1000 patients. Heart 82 (1999) II-27-II-34
3. Greenberg D., Bakhai A., and Cohen D.J. Can we afford to eliminate restenosis? Can we afford not to?. J Am Coll Cardiol 43 (2004) 513-518
4. Chen M.S., John J.M., Chew D.P., et al. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151 (2006) 1260-1264
5. Bainey K.R., Norris C.M., Graham M.M., et al. Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon?. Intern J Cardiol 128 (2008) 378-382
6. Assali A.R., Moustapha A., Sdringola S., et al. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (The PRESTO Trial). Am J Cardiol 98 (2006) 729-733
7. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005) 2126-2130
8. Pfisterer M., Brunner-La Rocca H.P., Buser P.T., et al., for the BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
9. Kuchulakanti P.K., Chu W.W., Torguson R., et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation 113 (2006) 1108-1113
10. Ong A.T.L., Hoye A., Aoki J., et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent Implantation. J Am Coll Cardiol 45 (2005) 947-953
11. Choussat R., Klersy C., Black A.J.R., et al. Long-term (8 years) outcome after Palmaz-Schatz stent implantation. Am J Cardiol 88 (2001) 10-16
12. Cutlip D.E., Chhabra A.G., Baim D.S., et al. Beyond restenosis. Five-year clinical outcomes from second-generation coronary stent trials. Circulation 110 (2004) 1226-1230
13. Ambrose J.A., Winters S.L., Stern A., et al. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 5 (1985) 609-616
14. Mauri L., Hsieh W.H., Massaro J.M., et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
15. Doyle B., Rihal C.S., O'Sullivan C.J., et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 116 (2007) 2391-2398
16. Lagerqvist B., James S.K., Stenestrand U., et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
17. Wenaweser P., Daemen J., Zwahlen M., et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 52 (2008) 1134-1140
18. Chechi T., Vecchio S., Vittori G., et al. ST-segment elevation myocardial infarction due to early and late stent thrombosis. A new group of high-risk patients. J Am Coll Cardiol 51 (2008) 2396-2402
19. Kaul S., Shah P.K., and Diamond G.A. As time goes by: current status and future directions in the controversy over stenting. J Am Coll Cardiol 50 (2007) 128-137
20. Mauri L., Silbaugh T.S., Wolf R.E., et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 118 (2008) 1817-1827
21. Stone G.W., Ellis S.G., Colombo A., et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 115 (2007) 2842-2847
22. Glaser R., Selzer F., Faxon D.P., et al. Clinical progression of incidental, asymptomatic lesions discovered during culprit vessel coronary intervention. Circulation 111 (2005) 143-149
23. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II. Euro Heart Survey Programme. Eur Heart J 22 (2001) 554-572